Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations

Leukemia(2024)10.1038/s41375-024-02312-9Source: DataRank Database

Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations is a research paper published in Leukemia (2024). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

geo nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 3.62)OA: greenTopics (74)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Dong Chen ORCID,James Ropa ORCID,Trupta Purohit ORCID,EunGi Kim ORCID,Maria‐Luisa Sulis

Live enrichment

PubMed:38890447 PMC:PMC11963213 OpenAlex:https://openalex.org/W4399775646

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01CA160467

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01CA272561

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: R01CA244254

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: K99 HL166790

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01 CA226759

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1R01 CA282082

Leukemia and Lymphoma Society

Grant: 6649-23

Alex's Lemonade Stand Foundation for Childhood Cancer

Grant: 22-25561

U.S. Department of Health & Human Services | NIH | Center for Scientific Review

Grant: F31 HL160072

NCI NIH HHS

Grant: R01 CA160467

NCI NIH HHS

Grant: R01 CA282082

NHLBI NIH HHS

Grant: F32 HL160072

NCI NIH HHS

Grant: R01 CA226759

NCI NIH HHS

Grant: R01 CA272561

National Institutes of Health

Grant: 5R01CA272561-03

Targeting Menin in Acute Leukemia with Upregulated HOX Genes

National Institutes of Health

Grant: 1K99HL166790-01

Omics interrogation of functionally competent hematopoieitic stem cells

National Institutes of Health

Grant: 1F32HL160072-01

Proteotranscriptomic regulation of homing and engraftment in hematopoietic stem and progenitor cells for hematopoietic cell transplantation

National Institutes of Health

Grant: 1R01CA282082-01

Targeting PRC1 in leukemia

National Institutes of Health

Grant: 5R01CA226759-02

Targeting NSD1 in leukemia

National Institutes of Health

Grant: 1R01CA160467-01

Development of novel anti-leukemia agents targeting the menin-MLL interaction

National Institutes of Health

Grant: 5R01CA244254-05

Development of ASH1L inhibitors for acute leukemia

U.S. Department of Health & Human Services | NIH | National Cancer Institute

FWCI

3.62

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/54e5a02c-4918-4fe7-be44-72ddaf9e3c4f/download

publisherhttps://www.nature.com/articles/s41375-024-02312-9.pdf

publisherhttps://www.nature.com/articles/s41375-024-02312-9

repositoryhttps://hdl.handle.net/1805/48126

Fields of Study

Protein Degradation and InhibitorsAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsHumansAnimalsNuclear Pore Complex ProteinsMiceProtein Kinase InhibitorsProto-Oncogene ProteinsTranslocation, GeneticXenograft Model Antitumor AssaysPiperazinesPyridinesCyclin-Dependent Kinase 6Leukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsCell ProliferationDrug Synergismfms-Like Tyrosine Kinase 3Cell Line, TumorAniline CompoundsPyrazines

MeSH Terms

Aniline CompoundsAnimalsAntineoplastic Combined Chemotherapy ProtocolsDrug SynergismHumansPiperazinesProto-Oncogene ProteinsPyrazinesPyridinesTranslocation, GeneticLeukemia, Myeloid, AcuteXenograft Model Antitumor AssaysNuclear Pore Complex ProteinsCell Line, TumorProtein Kinase InhibitorsCell ProliferationCyclin-Dependent Kinase 6Micefms-Like Tyrosine Kinase 3

Keywords

Cyclin-dependent kinase 6Cancer researchLeukemiaMyeloid leukemiaPalbociclibKinaseBiologyChromosomal translocationCell cycleCyclin-dependent kinaseCancerCell biologyImmunologyGeneticsGeneAniline CompoundsPyridinesDrug SynergismXenograft Model Antitumor AssaysTranslocation, GeneticPiperazinesNuclear Pore Complex ProteinsMiceLeukemia, Myeloid, Acutefms-Like Tyrosine Kinase 3Proto-Oncogene ProteinsCell Line, TumorPyrazinesAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsProtein Kinase InhibitorsCell Proliferation

Sustainable Development Goals

SDG 0: Good health and well-being

Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations

FAIR Checklist

Authors (9)

Funding (22 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)